SCHEMBL6440080

SCHEMBL6440080

O=C(O)c1cc2c(Cl)coc2cn1.OCc1cc2ccoc2cn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 2/20 0.40
CHRNA7 P36544 6/20 0.35
HTR3A P46098 3/20 0.34
HTR3E A5X5Y0 1/20 0.34
HTR3B O95264 1/20 0.34
HTR3D Q70Z44 1/20 0.34
HTR3C Q8WXA8 1/20 0.34
DYRK1A Q13627 1/20 0.34
TRPM8 Q7Z2W7 1/20 0.31
GABRP O00591 1/20 0.30
GABRD O14764 1/20 0.30
GABRA1 P14867 1/20 0.30
GABRB1 P18505 1/20 0.30
GABRG2 P18507 1/20 0.30
GABRB3 P28472 1/20 0.30
GABRA5 P31644 1/20 0.30
GABRA3 P34903 1/20 0.30
GABRA2 P47869 1/20 0.30
GABRB2 P47870 1/20 0.30
GABRA4 P48169 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL844180 0.81 DAO (0.41) KMOGABRPGABRDGABRA1GABRB1
SCHEMBL844226 0.77 ALDH1A1 (0.37)
SCHEMBL104140 0.77 DYRK1A (0.37) KMOCHRNA7HTR3AHTR3EHTR3B
SCHEMBL842797 0.75 KMO (0.57) KMOCHRNA7HTR3AHTR3EHTR3B
SCHEMBL29890580 0.75 KMO (0.57) KMOCHRNA7HTR3AHTR3EHTR3B
SCHEMBL844863 0.70 KMO (0.54) KMOCHRNA7HTR3AHTR3EHTR3B
SCHEMBL29892144 0.66 CHRNA7 (0.52) KMOCHRNA7HTR3AHTR3EHTR3B
SCHEMBL6263910 0.66 CHRNA7 (0.52) KMOCHRNA7HTR3AHTR3EHTR3B
SCHEMBL10555583 0.65 ALDH1A1 (0.36) KMODYRK1AMRGPRX4CTNNB1WNT3A
SCHEMBL844015 0.65 MTNR1A (0.43) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1572300-A1 COMBINATION FOR THE TREATMENT OF ADHD Pharmacia & Upjohn Company LLC (US) 2005-09-14 EP disclosed
WO-2004052461-A1 COMBINATION FOR THE TREATMENT OF ADHD PHARMACIA & UPJOHN COMPANY LLC (US) 2004-06-24 WO disclosed